Company intelligence / Profile preview

IgG of America

Linthicum, Maryland, United States

Ownership: Private
Development stage: Other

Overview

IgG of America was a specialized healthcare company focused on the distribution and administration of Intravenous Immunoglobulin (IVIG) therapies. The company operated as a specialty pharmacy, providing home infusion services and clinical support for patients with rare and chronic immunological and neurological diseases. Founded in 1994 and headquartered in Maryland, it established a significant market presence in the IVIG sector. In June 2006, the company was acquired by BioScrip, Inc. for approximately $46 million. Its service model emphasized high-touch patient care and coordination with healthcare providers to manage complex treatment regimens.

Therapeutic areas: HematologyImmunologyNeurology
Modalities: BiologicProtein
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on IgG of America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IgG of America.

Explore the full profile